Connect with us

Vitamin Patches Online

The never ending Biogen Alzheimer’s drug saga delivers yet another twist

Business

The never ending Biogen Alzheimer’s drug saga delivers yet another twist

Published

3 years ago

on

9 July 2021

By

Terry Power

The never ending Biogen Alzheimer’s drug saga delivers yet another twist

The drama of the FDA’s approval of Biogen’s Aduhelm is far from over. But what happens next? Read More

Related Topics:aducanumab aduhelm label aduhelm prescription Alzheimers biogen biogen aduhelm label coronavirus COVID COVID-19 delivers drug FDA fda aduhelm label fda biogen fda biogen approval food and drug administration saga twist

Elizabeth Warren asked the SEC for info on crypto regulation

Google plays with new antitrust allegations

Continue Reading

Business

These fast-growing Sun Belt cities suffer from high inflation

Published

3 years ago

on

4 May 2022

By

Terry Power

These fast-growing Sun Belt cities suffer from high inflation

U.S. migration hotspots tend to have the highest inflation | Fortune

Continue Reading

Business

The U.S. is seizing a $325 million helipad-equipped megayacht in Fiji. The question is which Russian oligarch it belongs to

Published

3 years ago

on

4 May 2022

By

Terry Power

Oligarch sanctions: U.S. seizing $325 million megayacht in Fiji. The question is which Russian billionaire it belongs to | Fortune

Continue Reading

Business

Investors bank on today’s ‘once-in-a-generation’ Fed hike to be one of several

Published

3 years ago

on

4 May 2022

By

Terry Power

Investors bank on today's 'once-in-a-generation' Fed hike to be one of several

Fed rate hike: decision day rattles markets as investors worry that a giant ‘once-in-a-generation’ hike will be one of several this year | Fortune

Continue Reading